New Colorimetric Cytotoxicity Assay for Anticancer-Drug Screening

Clicks: 3
ID: 289224
1990
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Popular

Ranked #247 of 335 articles by views in JNCI Journal of the National Cancer Institute

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 335 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Journal Article New Colorimetric Cytotoxicity Assay for Anticancer-Drug Screening Get access Philip Skehan, Philip Skehan * Developmental Therapeutics Program, Division of Cancer Treatment * Correspondence to: Philip Skehan, M.D., Developmental Therapeutics Program, Division of Cancer Treatment, Bldg. 560, Rm. 3260, National Cancer Institute, Frederick Cancer Research Facility, Frederick, MD 21701 Search for other works by this author on: Oxford Academic PubMed Google Scholar Ritsa Storeng, Ritsa Storeng Developmental Therapeutics Program, Division of Cancer Treatment Search for other works by this author on: Oxford Academic PubMed Google Scholar Dominic Scudiero, Dominic Scudiero Program Resources, Inc., National Cancer Institute, Frederick Cancer Research FacilityFrederick, MD. Search for other works by this author on: Oxford Academic PubMed Google Scholar Anne Monks, Anne Monks Program Resources, Inc., National Cancer Institute, Frederick Cancer Research FacilityFrederick, MD. Search for other works by this author on: Oxford Academic PubMed Google Scholar James McMahon, James McMahon Developmental Therapeutics Program, Division of Cancer Treatment Search for other works by this author on: Oxford Academic PubMed Google Scholar David Vistica, David Vistica Developmental Therapeutics Program, Division of Cancer Treatment Search for other works by this author on: Oxford Academic PubMed Google Scholar Jonathan T. Warren, Jonathan T. Warren Developmental Therapeutics Program, Division of Cancer Treatment Search for other works by this author on: Oxford Academic PubMed Google Scholar Heidi Bokesch, Heidi Bokesch Program Resources, Inc., National Cancer Institute, Frederick Cancer Research FacilityFrederick, MD. Search for other works by this author on: Oxford Academic PubMed Google Scholar Susan Kenney, Susan Kenney Developmental Therapeutics Program, Division of Cancer Treatment Search for other works by this author on: Oxford Academic PubMed Google Scholar Michael R. Boyd Michael R. Boyd Developmental Therapeutics Program, Division of Cancer Treatment, National Cancer InstituteBethesda, MD. Search for other works by this author on: Oxford Academic PubMed Google Scholar JNCI: Journal of the National Cancer Institute, Volume 82, Issue 13, 4 July 1990, Pages 1107–1112, https://doi.org/10.1093/jnci/82.13.1107 Published: 04 July 1990 Article history Received: 05 September 1980 Revision received: 11 December 1989 Accepted: 15 March 1990 Published: 04 July 1990
Reference Key
openalex_W2109689528 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Philip Skehan, Ritsa Storeng, Dominic A. Scudiero, Anne Monks, jeannette mcmahon, David T. Vistica, James T. Warren, Heidi R. Bokesch, Susan Kenney, M. R. Boyd
Journal JNCI Journal of the National Cancer Institute
Year 1990
DOI
10.1093/jnci/82.13.1107
URL
https://doi.org/10.1093/jnci/82.13.1107
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.